Global Hepatitis C Drugs Market 2011-2015 - Latest Report
The Global Hepatitis C Drugs market to grow at a CAGR of 28 percent over the period 2011–2015. One of the key factors contributing to this market growth is the increasing prevalence of hepatitis C infection. The Global Hepatitis C Drugs market has also been witnessing the shift of treatments from multiple drug therapy to single drug therapy. However, the virus developing resistance to the drugs could pose a challenge to the growth of this market.
View full press release